Cargando…

Participation of MCP-induced protein 1 in lipopolysaccharide preconditioning-induced ischemic stroke tolerance by regulating the expression of proinflammatory cytokines

BACKGROUND: Lipopolysaccharide (LPS) preconditioning-induced neuroprotection is known to be related to suppression of the inflammatory response in the ischemic area. This study seeks to determine if monocyte chemotactic protein-induced protein 1 (MCPIP1), a recently identified CCCH Zn finger-contain...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Jian, Wang, Jing, Saad, Yasser, Warble, Logan, Becerra, Edilu, Kolattukudy, Pappachan E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3260209/
https://www.ncbi.nlm.nih.gov/pubmed/22196138
http://dx.doi.org/10.1186/1742-2094-8-182
_version_ 1782221459312082944
author Liang, Jian
Wang, Jing
Saad, Yasser
Warble, Logan
Becerra, Edilu
Kolattukudy, Pappachan E
author_facet Liang, Jian
Wang, Jing
Saad, Yasser
Warble, Logan
Becerra, Edilu
Kolattukudy, Pappachan E
author_sort Liang, Jian
collection PubMed
description BACKGROUND: Lipopolysaccharide (LPS) preconditioning-induced neuroprotection is known to be related to suppression of the inflammatory response in the ischemic area. This study seeks to determine if monocyte chemotactic protein-induced protein 1 (MCPIP1), a recently identified CCCH Zn finger-containing protein, plays a role in focal brain ischemia and to elucidate the mechanisms of LPS-induced ischemic brain tolerance. METHODS: Transcription and expression of MCPIP1 gene was monitored by qRT-PCR and Western blot. Mouse microglia was prepared from cortices of C57BL/6 mouse brain and primary human microglia was acquired from Clonexpress, Inc. Wild type and MCPIP1 knockout mice were treated with LPS (0.2 mg/kg) 24 hours before brain ischemia induced by transient middle cerebral artery occlusion (MCAO). The infarct was measured by 2,3,5-triphenyltetrazolium chloride (TTC) staining. RESULTS: MCPIP1 protein and mRNA levels significantly increased in both mouse and human microglia and mouse brain undergoing LPS preconditioning. MCPIP1 mRNA level significantly increased in mice ipsilateral brain than that of contralateral side after MCAO. The mortality of MCPIP1 knockout mice was significantly higher than that of wild-type after MCAO. MCPIP1 deficiency caused significant increase in the infarct volume compared with wild type mice undergoing LPS preconditioning. MCPIP1 deficiency caused significant upregulation of proinflammatory cytokines in mouse brain. Furthermore, MCPIP1 deficiency increased c-Jun N terminal kinase (JNK) activation substantially. Inhibition of JNK signaling decreased the production of proinflammatory cytokines in MCPIP1 knock out mice after MCAO. CONCLUSIONS: Our data indicate that absence of MCPIP1 exacerbates ischemic brain damage by upregulation of proinflammatory cytokines and that MCPIP1 participates in LPS-induced ischemic stroke tolerance.
format Online
Article
Text
id pubmed-3260209
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-32602092012-01-18 Participation of MCP-induced protein 1 in lipopolysaccharide preconditioning-induced ischemic stroke tolerance by regulating the expression of proinflammatory cytokines Liang, Jian Wang, Jing Saad, Yasser Warble, Logan Becerra, Edilu Kolattukudy, Pappachan E J Neuroinflammation Research BACKGROUND: Lipopolysaccharide (LPS) preconditioning-induced neuroprotection is known to be related to suppression of the inflammatory response in the ischemic area. This study seeks to determine if monocyte chemotactic protein-induced protein 1 (MCPIP1), a recently identified CCCH Zn finger-containing protein, plays a role in focal brain ischemia and to elucidate the mechanisms of LPS-induced ischemic brain tolerance. METHODS: Transcription and expression of MCPIP1 gene was monitored by qRT-PCR and Western blot. Mouse microglia was prepared from cortices of C57BL/6 mouse brain and primary human microglia was acquired from Clonexpress, Inc. Wild type and MCPIP1 knockout mice were treated with LPS (0.2 mg/kg) 24 hours before brain ischemia induced by transient middle cerebral artery occlusion (MCAO). The infarct was measured by 2,3,5-triphenyltetrazolium chloride (TTC) staining. RESULTS: MCPIP1 protein and mRNA levels significantly increased in both mouse and human microglia and mouse brain undergoing LPS preconditioning. MCPIP1 mRNA level significantly increased in mice ipsilateral brain than that of contralateral side after MCAO. The mortality of MCPIP1 knockout mice was significantly higher than that of wild-type after MCAO. MCPIP1 deficiency caused significant increase in the infarct volume compared with wild type mice undergoing LPS preconditioning. MCPIP1 deficiency caused significant upregulation of proinflammatory cytokines in mouse brain. Furthermore, MCPIP1 deficiency increased c-Jun N terminal kinase (JNK) activation substantially. Inhibition of JNK signaling decreased the production of proinflammatory cytokines in MCPIP1 knock out mice after MCAO. CONCLUSIONS: Our data indicate that absence of MCPIP1 exacerbates ischemic brain damage by upregulation of proinflammatory cytokines and that MCPIP1 participates in LPS-induced ischemic stroke tolerance. BioMed Central 2011-12-24 /pmc/articles/PMC3260209/ /pubmed/22196138 http://dx.doi.org/10.1186/1742-2094-8-182 Text en Copyright ©2011 Liang et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Liang, Jian
Wang, Jing
Saad, Yasser
Warble, Logan
Becerra, Edilu
Kolattukudy, Pappachan E
Participation of MCP-induced protein 1 in lipopolysaccharide preconditioning-induced ischemic stroke tolerance by regulating the expression of proinflammatory cytokines
title Participation of MCP-induced protein 1 in lipopolysaccharide preconditioning-induced ischemic stroke tolerance by regulating the expression of proinflammatory cytokines
title_full Participation of MCP-induced protein 1 in lipopolysaccharide preconditioning-induced ischemic stroke tolerance by regulating the expression of proinflammatory cytokines
title_fullStr Participation of MCP-induced protein 1 in lipopolysaccharide preconditioning-induced ischemic stroke tolerance by regulating the expression of proinflammatory cytokines
title_full_unstemmed Participation of MCP-induced protein 1 in lipopolysaccharide preconditioning-induced ischemic stroke tolerance by regulating the expression of proinflammatory cytokines
title_short Participation of MCP-induced protein 1 in lipopolysaccharide preconditioning-induced ischemic stroke tolerance by regulating the expression of proinflammatory cytokines
title_sort participation of mcp-induced protein 1 in lipopolysaccharide preconditioning-induced ischemic stroke tolerance by regulating the expression of proinflammatory cytokines
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3260209/
https://www.ncbi.nlm.nih.gov/pubmed/22196138
http://dx.doi.org/10.1186/1742-2094-8-182
work_keys_str_mv AT liangjian participationofmcpinducedprotein1inlipopolysaccharidepreconditioninginducedischemicstroketolerancebyregulatingtheexpressionofproinflammatorycytokines
AT wangjing participationofmcpinducedprotein1inlipopolysaccharidepreconditioninginducedischemicstroketolerancebyregulatingtheexpressionofproinflammatorycytokines
AT saadyasser participationofmcpinducedprotein1inlipopolysaccharidepreconditioninginducedischemicstroketolerancebyregulatingtheexpressionofproinflammatorycytokines
AT warblelogan participationofmcpinducedprotein1inlipopolysaccharidepreconditioninginducedischemicstroketolerancebyregulatingtheexpressionofproinflammatorycytokines
AT becerraedilu participationofmcpinducedprotein1inlipopolysaccharidepreconditioninginducedischemicstroketolerancebyregulatingtheexpressionofproinflammatorycytokines
AT kolattukudypappachane participationofmcpinducedprotein1inlipopolysaccharidepreconditioninginducedischemicstroketolerancebyregulatingtheexpressionofproinflammatorycytokines